tirzepatide shortage 2025 The GLP-1 drug is over. What's next for the compounders? - Pharma Technology Focus | Issue 154 Empower Pharmacy tirzepatide: products, safety,

Initial research suggests that GLP-1 receptor agonists may help protect against neurodegenerative diseases such as Alzheimers

Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: beyond leptin and ghrelin

Also, curcumin, selenium, vitamins C and E are cofactors that promote glutathione absorption and consumption. But as is often the case, stressed-out modern life can translate to a sub-optimal nutrient intake

Choosing when to take your weekly tirzepatide injection is an important practical consideration for patients starting this medication

Patent expirations, generics competition, and a global surge in metabolic drug development could dramatically increase the number of trials targeting obesity and metabolic disease